<< Back
Revenue (FY)
This is the sum of all revenue (sales) reported for all operating divisions.
NASDAQ (US Dollar)
$82.62
 Stock is Down 0.02 (0.02%)
Data as of 09/21/17 4:00 p.m. ET
Minimum 20 minute delay
Refresh Quote
Recent Webcasts
Gilead Sciences at Morgan Stanley Global Healthcare Conference

September 11, 2017 9:55 a.m. ET
Play
Gilead Sciences at Citi’s 12th Annual Biotech Conference

September 06, 2017 11:00 a.m. ET
Play
Gilead Sciences Business Update

August 28, 2017 8:00 a.m. ET
Play